Best Cards to Grade in Facing a New Trial
16 Facing a New Trial cards ranked by grading ROI. Wailord 016/49 leads at 7.4x ($4.99 raw vs $280.00 in PSA 10). Live prices, PSA gem rates and population.
ROI is the PSA 10 price against the raw price plus grading cost and PSA's value-tier upcharge, from live market prices and PSA population data. Cards are ranked highest ROI first.
| Rank | Card | Raw | PSA 10 | Gem rate | PSA 10 pop | ROI |
|---|---|---|---|---|---|---|
| 1 | Wailord 016/49 | $4.99 | $280.00 | 71.4% | 20 | 7.4x |
| 2 | Lycanroc GX 054/49 | $9.00 | $181.24 | 63.2% | 12 | 4.3x |
| 3 | Slowking 023/49 | $4.76 | $162.75 | 88.6% | 101 | 4.3x |
| 4 | Alolan Sandshrew 011/49 | $4.33 | $150.00 | 81.2% | 13 | 4.0x |
| 5 | Slowpoke 022/49 | $8.08 | $118.50 | 84.1% | 132 | 2.9x |
| 6 | Sableye 039/49 | $6.94 | $109.50 | 94.1% | 16 | 2.7x |
| 7 | Sophocles 057/49 | $61.38 | $239.00 | 57.1% | 186 | 2.5x |
| 8 | Acerola 056/49 | $2,397.19 | $7,000.00 | 32.5% | 561 | 2.3x |
| 9 | Komala 043/49 | $5.17 | $60.91 | 100.0% | 1 | 1.6x |
| 10 | Alolan Vulpix 013/49 | $6.28 | $60.16 | 76.5% | 62 | 1.5x |
6 more Facing a New Trial cards are ranked for Pro members.